RBC Capital Bullish On Opus Genetics (IRD) Amid Limited Competition And De-Risked Setup

6 7 月, 2026

One Min Read

1 Views

原文: https://finance.yahoo.com/healthcare/articles/rbc-capital-bullish-opus-genetics-220802963.html

Last Update: 6 7 月, 2026

Written By

Other Articles

Previous

Here’s Why H.C. Wainwright Upgraded Prime Medicine (PRME) To “Buy”

Next

Why Is H.C. Wainwright Bullish On SAB Biotherapeutics (SABS) With $10 Price Target?

Related Posts

Powerball jackpot soars to $1.3 billion. Here’s what the winner will take home after taxes.

1 Min Read

What is force-placed car insurance, and when do lenders require it?

1 Min Read

Do you need collateral for a personal loan? See when it might help.

1 Min Read

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept